What's New at Wisconsin Institute of Urology

Join us for a night to discuss bladder and bowel control with our very own Dr. Erin Salter on Wednesday, May 10 from 6-7 pm

To register, visit https://tinyurl.com/DrSalterTAP

More than 37 million adults in the United States — almost one in six — suffer from overactive bladder (OAB)^1,2 and nearly 18 million Americans — about one in 12 — are living with fecal incontinence.^3,4 Many sufferers limit their lives socially, professionally, and personally.⁵ However, as many as 45% who suffer from symptoms do not seek treatment and as many as seven in 10 stop using medications within six months due to intolerable side effects or unsatisfying results.^6,7,8

These symptoms may be causing you or a loved one to say “no” to activities you love:

• Uncontrollable urges to go to the bathroom.
• Frequent accidents resulting in wearing pads.
• Getting up multiple times at night.

You are not alone. Find relief today! Join Dr. Erin Salter from Wisconsin Institute of Urology for a free educational event, “Discover treatment options for bladder and bowel control”, on Wednesday, May 10 6:00 to 7:00 p.m., and learn options for treatment and control. This will be a hybrid event where you can participate online from your home computer or join us in person at Wisconsin Institute of Urology, 1265 W American Dr #100, Neenah, WI 54956.

To register, visit https://tinyurl.com/DrSalterTAP.

“Bladder and bowel incontinence is common, but it’s not a normal part of aging. It’s annoying, inconvenient, and frustrating, and can significantly impact a person’s self-confidence, exercise, activities and even intimacy,” said Dr. Erin Salter. “The good news is it’s treatable.”

Wisconsin Institute of Urology is dedicated to service through compassionate patient-centered care, promoting a partnership between provider, patient, and community while adhering to the highest standards of integrity and excellence. We are committed to progressive and innovative care, using state-of-the-art technology with the most cost-effective means possible.

1. Stewart WF, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003 May;20(6):327-336.
2. United Nations, Department of Economic and Social Affairs, Population Division (2011). World Population Prospects: The 2010 Revision, CD-ROM Edition.
3. Whitehead WE, Borrud L, Goode PS, et al. Pelvic floor disorders network. Fecal incontinence in US adults: epidemiology and risk factors. Gastroenterology. 2009;137: 512-517.
4. United States Quick Facts. United States Census Bureau Web site. Available at: https://www.census.gov/quickfacts/table/ PST045215/00. Accessed July 19, 2016.
5. Dmochowski RR, Newman DK. Impact of overactive bladder on women in the United States: results of a national survey. Current Medical Research and Opinion. 2007;23:65-76.
6. Leede Research, “Views on OAB: A Study for the National Association of Continence.” December 16, 2015.
7. Yu YF, Nichol MB, Yu AP, et al. Persistence and adherence of medications for chronic overactive bladder/urinary incontinence in the California Medicaid Program. Value in Health. 2005;8(4)495-505.
8. Yeaw J, Benner JS, Walt JG, Sian S, Smith DB, et al. J Manag Care Pharm. 2009;15(9):728-740.